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Receptor-associated protein kinase activity has been shown in all primary target tissues of insulin action 
in the rat and a function of insulin receptor phosphorylation in signal transmission was proposed. Insulin 
receptor phosphorylation so far has not been demonstrated in human target tissues of insulin. We describe 
here insulin receptor kinase activity in human skeletal muscle. Insulin ( 10m8 mol/l) stimulates the phospho- 
rylation of a 95-kDa protein from skeletal muscle 2-fold. The phosphoprotein is quantitatively immunopre- 
cipitated with insulin receptor antibody identifying it as the j%subunit of the insulin receptor. The insulin 
stimulation of phosphorylation is detectable also at physiological insulin concentrations ( 1O-g mol/l) 
showing that receptor phosphorylation could be involved in insulin action in human skeletal muscle as well. 
Human skeletal muscle Insulin receptor 
1. INTRODUCTION 
Insulin-stimulated phosphorylation of the 
95-kDa P-subunit of the insulin receptor was first 
demonstrated in 1982 [l]. This phenomenon has 
since been intensively studied [2-lo]. The 
characteristics of insulin stimulation of the insulin 
receptor kinase and of the phosphorylation of the 
insulin receptor in the main target tissues of the 
metabolic effects of insulin in rats, namely liver 
[2,4,7-91, adipose tissue [3] and the muscle [lo] 
have suggested that the increase of the receptor 
kinase activity might be the first post-binding step 
in cellular insulin action which transmits the in- 
sulin signal across the plasma membrane. Insulin 
receptor kinase activity has thus far not been 
demonstrated in the main target tissues of insulin 
action in man. Here we studied insulin receptor 
phosphorylation in human skeletal muscle for two 
reasons: (i) Receptor kinase activity and its 
stimulation by physiological insulin concentrations 
has to be demonstrated in human target tissues to 
be able to discuss receptor phosphorylation as part 
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of the mechanism of insulin signal transmission in 
humans. (ii) Insulin resistance in type-II diabetes 
appears to be caused predominantly by a post- 
binding defect of insulin action in muscle [ 111. Im- 
paired insulin receptor kinase activity is a possible 
cause of insulin resistance [12- 141. Therefore, it is 
of great interest for the further characterization of 
the post-binding defect in type-II diabetes if a 
measurement of receptor kinase activity is feasible 
in small amounts of skeletal muscle which could be 
obtained from patients. 
2. MATERIALS AND METHODS 
2.1. Materials 
Porcine insulin was purchased from Novo In- 
dustrie (Denmark), [32P]ATP (2900 Ci/mmol) and 
Triton X-100 were from NEN (FRG), aprotinin, 
phenylmethylsulfonyl fluoride (PMSF), leupeptin, 
and pepstatin were from Sigma (FRG). Wheat 
germ agglutinin coupled to agarose was from 
Miles, all reagents for SDS-polyacrylamide gel 
electrophoresis were from Bio-Rad, all other 
reagents were of the best grade commercially 
available. 
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2.2. Methods 3. RESULTS 
Human skeletal muscle was obtained from 5 pa- 
tients undergoing plastic reconstruction of the 
breast by myocutaneous flap. 2-5 g fresh muscle 
were used for each preparation. The receptor was 
prepared as described for rat skeletal muscle [lo]. 
Briefly, skeletal muscle tissue was homogenized by 
an ultraturrax in the presence of the protease in- 
hibitors PMSF (5 mmol/l), aprotinin (1200 trypsin 
inhibiting units/l), leupeptin (2 pmol/l), pepstatin 
(2 pmol/l), benzamidine (10 mmol/l), bacitracin 
(7500 U/l), leucine (10 mmol/l) in a buffer con- 
taining NaH2POd (pH 7.4, 22”C, 10 mmol/l), 
EDTA (5 mmol/l), sucrose (250 mmol/l). The 
homogenates were centrifuged at 200000 x g for 
50 min and the pellet was then solubilized with 
Triton X-100 at a final concentration of 1% (by 
vol.) in a buffer containing Hepes (25 mmol/l, pH 
7.4, 22°C) and the protease inhibitors aprotinin 
(600 TIU/l), pepstatin (2 pmol/l), leupeptin (2 
pmol/l) and PMSF (2 mmol/l). Insoluble material 
was removed by centrifugation at 200000 x g for 
50 min. The clear supernatant was applied to 
columns (1 x 2.5 cm) of wheat germ agglutinin 
coupled to agarose with addition of 150 mmol/l 
NaCl and the same volume of Hepes buffer 
(25 mmol/l, pH 7.4, 22°C). The column was 
washed with 30-40 ml of a buffer containing 
25 mmol/l Hepes, and 0.1% (by vol.) Triton 
X-100 and then the bound material was eluted with 
10 ml of the washing buffer supplemented with 
0.3 mol/l N-acetylglucosamine (flow rate 50-60 
ml/h). 0.5-m] fractions of the eluate were col- 
lected, protein content and “‘1 binding were deter- 
mined as described [9] and the peak fractions were 
used for further studies. For the standard phos- 
phorylation assay approx. 1 pug wheat germ 
purified protein was preincubated at 22°C for 30 
min with insulin in different concentrations 
(10-‘“-10-7 mol/l) or without insulin followed by 
an incubation with [32P]ATP (5 or 40rmol/l) in 
elution buffer containing 10 mmol/l MnC12 and 
1 mmol/l vanadate at 22°C for 15 min. The in- 
cubation was stopped by addition of Laemmli buf- 
fer and boiling for 30 min. Subsequently phospho- 
proteins were separated by polyacrylamide gel elec- 
trophoresis and identified by autoradiography. 
The phosphoproteins identified by the autoradiog- 
raphy were cut out from the gel and counted in a 
scintillation counter. 
Muscle of 5 patients (2-5 g wet tissue each) were 
obtained and the wheat germ purification pro- 
cedure was performed as described in section 2. 
Three preparations yielded a sufficient amount of 
receptor kinase activity and these preparations 
were used for further studies. When the proteins 
partially purified by the wheat germ affinity pro- 
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Fig.1. Autoradiogram of the phosphorylation of the 
insulin receptor from human skeletal muscle. Wheat 
germ affinity purified receptor from human skeletal 
muscle was incubated for 30 min at room temperature 
with insulin (10-E mol/l). Phosphorylation was studied 
at 22°C with [3ZP]ATP (40 pmol, 0.01 mCi) for 15 min. 
1 pg protein was used in each assay. The reaction was 
stopped by boiling in Laemmli buffer. Phosphoproteins 
were analysed by SDS 10% polyacrylamide gel 
electrophoresis. Lane A shows phosphorylation in the 
absence of insulin, lane B in the presence of insulin. In 
the experiments shown in lanes C and D, 
phosphorylation was not stopped by boiling but by 
addition of a stopping solution (200 mmol/l NaF, 
20 mmol/l sodium pyrophosphate, 10 mmol/l EDTA, 
10 mmol/l ATP, 0.4 mmol/l vanadate and 2400 TIU/l 
aprotinin). The phosphoproteins were then immunopre- 
cipitated with insulin receptor antibody containing 
serum. Lane C shows the immunoprecipitate after 
stimulation of phosphorylation with insulin. Lane D 
shows the supernatant of the immunoprecipitate of 
insulin-stimulated phosphoproteins. Immunoprecipi- 
tates and supernatant were analyzed by SDS 10% poly- 
acrylamide gel electrophoresis. 
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cedure were incubated with insulin for 30 min 
followed by a 15 min phosphorylation period, in- 
creased 32P incorporation was seen in a 95-kDa 
band (fig. 1, lanes A,B). If the phosphorylated pro- 
teins were immunoprecipitated with a serum con- 
taining insulin receptor antibody, the 9%kDa pro- 
tein was quantitatively precipitated (fig. 1, lane C) 
while no precipitation was seen with control serum 
(not shown), and no phosphorylation was seen in 
the supernatant of the immunoprecipitate (fig. 1, 
lane D). This identifies the phosphorylated 95kDa 
protein as the P-subunit of the insulin receptor. 
The stimulation of receptor phosphorylation by 
insulin can also be demonstrated at insulin concen- 
trations in the physiological range. Fig.2 shows the 
dose-response curve of insulin stimulation of 
phosphorylation of muscle receptor. At 10e9 mol/l 
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Fig.2. Dependence of insulin receptor phosphorylation 
on insulin concentration. Dose-response curve of insulin 
action on phosphorylation of the 95-kDa subunit of the 
insulin receptor. Wheat germ affinity purified receptor 
from skeletal muscle was incubated for 30 min at room 
temperature with insulin (10-10-10-7 mol/l). Phospho- 
rylation was studied at 22°C with [Y-~~P]ATP (40 rmol, 
0.01 ,&i) for 15 min. 1 ,ug protein was used in each 
assay. The reaction was stopped by boiling in Laemmli 
buffer. Phosphoproteins were analysed by SDS 10% 
polyacrylamide gel electrophoresis. The 95-kDa band 
was identified by autoradiography and the band was cut 
out from the gel and counted in a scintillation counter. 
A control band of equal size was counted to determine 
background activity and the value was subtracted from 
the value found in the 95-kDa band. 
insulin a half-maximal effect is reached 
approximately. 
4. DISCUSSION 
Human skeletal muscle contains receptor kinase 
which is activated by physiological insulin concen- 
trations. Activation of insulin receptor kinase and 
autophosphorylation of the receptor had been in- 
tensively characterized in animal tissues, human 
non-target tissues and cell culture [l-lo]. Kinetic 
properties, specificity and insulin sensitivity of 
receptor phosphorylation in rat liver cells [4], rat 
hepatoma cells [2,8,9], rat fat cells [3] and rat mus- 
cle [lo] support the idea that this is the first signal 
transmitting step which follows insulin binding. 
The present findings in human skeletal muscle 
would be compatible with this model of insulin ac- 
tion. If the results obtained here with the human 
muscle are compared with the characteristics 
found in rat skeletal muscle [lo] it is evident that 
the stimulation of receptor phosphorylation in the 
human tissue is much lower, 2-fold, compared to 
a IO-16-fold stimulation in the rat. However, this 
parallels characteristics of other insulin effects 
such as the stimulation of glucose transport in fat, 
where a 7-lo-fold stimulation is found in the rat 
tissue [ 151, whereas the stimulation in the human 
tissue is only 2-3-fold [ 161. 
The second purpose of this study was to deter- 
mine how receptor kinase activity can be studied in 
muscle of type II diabetic patients. Based on 
glucose clamp studies in type II diabetics [l I] it 
was suggested that insulin resistance in these pa- 
tients is predominantly caused by an impaired in- 
sulin effect in skeletal muscle. On the other hand, 
several studies have appeared now [ 12-141 which 
showed that decreased receptor autophosphoryla- 
tion is found in several situations with insulin 
resistance. The study of receptor autophosphoryla- 
tion in muscle of type II diabetic patients should 
clarify if an abnormality of receptor kinase con- 
tributes to the insulin resistance in these patients. 
Based on the present results the small amounts of 
muscle tissue which can be obtained by biopsy [ 171 
and which were used to study insulin binding are 
not yet sufficient to study receptor kinase. A 
substrate assay of the kinase might solve this 
problem and this question is currently under 
investigation. 
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